Abstract: The disclosure provides a lighting device that provides light via one or more non-incandescent lamps that can be moved and arranged while operating. The lighting device includes a non-opaque shroud, or casing, that sits upon a base to create a volume within which the non-incandescent lamps rest and can be moved while still providing light. The non-incandescent lamp can use one or more light-emitting diodes (LEDs). The non-incandescent lamps can provide illumination with minimal heat and low power consumption that contributes to user interaction and can be battery powered. In addition to a non-incandescent lamp, a lighting device having at least one of the non-incandescent lamps is disclosed. Additionally, a lighting system having at least one of the lighting devices and a lighting control application is provided herein.

Abstract: The disclosure provides a lighting device that provides light via one or more non-incandescent lamps that can be moved and arranged while operating. The lighting device includes a non-opaque shroud, or casing, that sits upon a base to create a volume within which the non-incandescent lamps rest and can be moved while still providing light. The non-incandescent lamp can use one or more light-emitting diodes (LEDs). The non-incandescent lamps can provide illumination with minimal heat and low power consumption that contributes to user interaction and can be battery powered. In addition to a non-incandescent lamp, a lighting device having at least one of the non-incandescent lamps is disclosed. Additionally, a lighting system having at least one of the lighting devices and a lighting control application is provided herein.

Abstract: The disclosure provides a lighting device that provides light via one or more non-incandescent lamps that can be moved and arranged while operating. The lighting device includes a non-opaque shroud, or casing, that sits upon a base to create a volume within which the non-incandescent lamps rest and can be moved while still providing light. The non-incandescent lamp can use one or more light-emitting diodes (LEDs). The non-incandescent lamps can provide illumination with minimal heat and low power consumption that contributes to user interaction and can be battery powered. In addition to a non-incandescent lamp, a lighting device having at least one of the non-incandescent lamps is disclosed. Additionally, a lighting system having at least one of the lighting devices and a lighting control application is provided herein.

Abstract: The disclosure provides a lighting device that provides light via one or more non- incandescent lamps that can be moved and arranged while operating. The lighting device includes a non-opaque shroud, or casing, that sits upon a base to create a volume within which the non-incandescent lamps rest and can be moved while still providing light. The non- incandescent lamp can use one or more light-emitting diodes (LEDs). The non-incandescent lamps can provide illumination with minimal heat and low power consumption that contributes to user interaction and can be battery powered. In addition to a non-incandescent lamp, a lighting device having at least one of the non-incandescent lamps is disclosed. Additionally, a lighting system having at least one of the lighting devices and a lighting control application is provided herein.

Abstract: The invention provides methods and compositions for identifying and quantifying pathological changes on the retina.

Abstract: The invention provides methods and compositions for identifying and quantifying pathological changes on the retina.

Abstract: Compositions of angiostatic agents for treating choroidal neovascularization resulting from ocular surgery or from trauma to ocular tissue and methods for their use are disclosed.

Abstract: Agents that stimulate nuclear translocation of Nrf2 protein and the subsequent increases in gene products that detoxify and eliminate cytotoxic metabolites are provided in a method for treating glaucomatous retinopathy or optic neuropathy. The structurally diverse agents that act on the Nrf2/ARE pathway induce the expression of enzymes and proteins that possess chemically versatile cytoprotective properties and are a defense against toxic metabolites and xenobiotics. Agents include certain electrophiles and oxidants such as a Michael Addition acceptor, diphenol, thiocarbamate, quinone, 1,2-dithiole-3-thione, butylated hydroxyanisole, flavonoid, an isothiocyanate, 3,5-di-tert-butyl-4-hydroxytoluene, ethoxyquin, a coumarin, combinations thereof, or a pharmacologically active derivative or analog thereof.

Abstract: Agents that stimulate nuclear translocation of Nrf2 protein and the subsequent increases in gene products that detoxify and eliminate cytotoxic metabolites are provided in a method for treating diabetic retinopathy or drusen formation in age-related macular degeneration. The structurally diverse agents that act on the Nrf2/ARE pathway induce the expression of enzymes and proteins that possess chemically versatile cytoprotective properties and are a defense against toxic metabolites and xenobiotics. Agents include certain electrophiles and oxidants such as a Michael Addition acceptor, diphenol, thiocarbamate, quinone, 1,2-dithiole-3-thione, butylated hydroxyanisole, flavonoid other than genistein, an isothiocyanate, 3,5-di-tert-butyl-4-hydroxytoluene, ethoxyquin, a coumarin, combinations thereof, or a pharmacologically active derivative or analog thereof.

Abstract: ASIC libraries generally have some form of multi-port register file with 2 or more write ports and 2-8 read ports. Such register files can be exploited to implement a memory system using less external logic (fewer external-to-the memory MUXes to achieve desired narrow read ports) and/or fewer RAM instances. The desired memory system (including a single multi-port RAM that is configured to have a single very-wide write port and multiple narrow read ports) will then no longer require multiple instances of RAMs, and will therefore require less area due to overall reduced bit density.